Private Trust Company’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.66K | Sell |
120
-73
| -38% | -$3.45K | ﹤0.01% | 2015 |
|
2025
Q1 | $7.54K | Hold |
193
| – | – | ﹤0.01% | 1900 |
|
2024
Q4 | $10.5K | Buy |
193
+34
| +21% | +$1.84K | ﹤0.01% | 1739 |
|
2024
Q3 | $8.02K | Buy |
159
+37
| +30% | +$1.87K | ﹤0.01% | 1804 |
|
2024
Q2 | $5.36K | Hold |
122
| – | – | ﹤0.01% | 1899 |
|
2024
Q1 | $6.13K | Sell |
122
-16
| -12% | -$804 | ﹤0.01% | 1834 |
|
2023
Q4 | $8.33K | Buy |
138
+41
| +42% | +$2.48K | ﹤0.01% | 1720 |
|
2023
Q3 | $5.53K | Buy |
97
+63
| +185% | +$3.59K | ﹤0.01% | 1827 |
|
2023
Q2 | $1.73K | Buy |
+34
| New | +$1.73K | ﹤0.01% | 2124 |
|